Adverum Biotechnologies Statistics
Total Valuation
ADVM has a market cap or net worth of $169.58 million. The enterprise value is $38.27 million.
Market Cap | 169.58M |
Enterprise Value | 38.27M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ADVM has 20.76 million shares outstanding. The number of shares has increased by 64.30% in one year.
Shares Outstanding | 20.76M |
Shares Change (YoY) | +64.30% |
Shares Change (QoQ) | +62.81% |
Owned by Insiders (%) | 1.20% |
Owned by Institutions (%) | 100.41% |
Float | 10.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.93 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.24, with a Debt / Equity ratio of 0.35.
Current Ratio | 9.24 |
Quick Ratio | n/a |
Debt / Equity | 0.35 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -90.40% and return on invested capital (ROIC) is -48.97%.
Return on Equity (ROE) | -90.40% |
Return on Assets (ROA) | -51.40% |
Return on Capital (ROIC) | -48.97% |
Revenue Per Employee | n/a |
Profits Per Employee | -$933,025 |
Employee Count | 121 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.94% in the last 52 weeks. The beta is 1.06, so ADVM's price volatility has been similar to the market average.
Beta (5Y) | 1.06 |
52-Week Price Change | -64.94% |
50-Day Moving Average | 7.81 |
200-Day Moving Average | 10.93 |
Relative Strength Index (RSI) | 52.91 |
Average Volume (20 Days) | 584,782 |
Short Selling Information
The latest short interest is 815,802, so 3.93% of the outstanding shares have been sold short.
Short Interest | 815,802 |
Short Previous Month | 866,174 |
Short % of Shares Out | 3.93% |
Short % of Float | 7.69% |
Short Ratio (days to cover) | 2.61 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -120.59M |
Pretax Income | -113.99M |
Net Income | -112.90M |
EBITDA | -96.84M |
EBIT | -113.99M |
Earnings Per Share (EPS) | -$10.20 |
Balance Sheet
The company has $195.30 million in cash and $63.99 million in debt, giving a net cash position of $131.31 million or $6.33 per share.
Cash & Cash Equivalents | 195.30M |
Total Debt | 63.99M |
Net Cash | 131.31M |
Net Cash Per Share | $6.33 |
Equity (Book Value) | 182.29M |
Book Value Per Share | 8.78 |
Working Capital | 177.58M |
Cash Flow
In the last 12 months, operating cash flow was -$91.74 million and capital expenditures -$813,000, giving a free cash flow of -$92.55 million.
Operating Cash Flow | -91.74M |
Capital Expenditures | -813,000 |
Free Cash Flow | -92.55M |
FCF Per Share | -$5.62 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ADVM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -64.30% |
Shareholder Yield | -64.30% |
Earnings Yield | -66.57% |
FCF Yield | -54.57% |
Analyst Forecast
The average price target for ADVM is $32.83, which is 301.84% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $32.83 |
Price Target Difference | 301.84% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 60.64% |
EPS Growth Forecast (5Y) | -19.73% |
Stock Splits
The last stock split was on March 21, 2024. It was a reverse split with a ratio of 1:10.
Last Split Date | Mar 21, 2024 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |